Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CB | Common Shares | Options Exercise | $1.8M | +13K | +16.67% | $139.01 | 90.7K | Mar 20, 2025 | Direct | |
transaction | CB | Common Shares | Sale | -$3.61M | -12.2K | -13.49% | $294.82 | 78.4K | Mar 20, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CB | Options to Acquire Common Shares | Options Exercise | $0 | -13K | -100% | $0.00 | 0 | Mar 20, 2025 | Common Shares | 13K | $139.01 | Direct | F2 |
holding | CB | Options to Acquire Common Shares | 62.2K | Mar 20, 2025 | Common Shares | Direct | F3 |
Id | Content |
---|---|
F1 | The Common Shares reported herein as being sold were sold at a range of between $294.1390 and $295.01 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
F2 | Options vested as follows: 1/3 on February 23, 2018, 1/3 on February 23, 2019 and 1/3 on February 23, 2020. |
F3 | Total includes previously reported options from other tranches with different exercise prices, vesting and expiration dates. |
*General Counsel